Literature DB >> 9738934

Identification of a novel human homolog of the Drosophila dlg, P-dlg, specifically expressed in the gland tissues and interacting with p55.

H Nakamura1, T Sudo, H Tsuiki, H Miyake, T Morisaki, J Sasaki, N Masuko, M Kochi, Y Ushio, H Saya.   

Abstract

We have identified a novel human homolog of the Drosophila dlg tumor suppressor gene, termed P-dlg, which has been mapped at chromosome 10q23. Unlike other human dlg homologs, P-dlg is expressed in placenta and various gland tissues but not in brain. The P-dlg protein is localized at the plasma membrane and cytoplasm, and it is expressed in the gland epithelial cells in normal prostate tissue but not in prostate cancer cell lines. Furthermore, we identified interaction between P-dlg and p55 palmitoylated membrane protein by yeast two-hybrid screening. These findings suggest that P-dlg forms a complex with p55 at the plasma membrane and plays roles in maintaining the structure of epithelial cells and transmitting extracellular signals to the membrane and cytoskeleton, which may negatively regulate cell proliferation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9738934     DOI: 10.1016/s0014-5793(98)00882-5

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  14 in total

Review 1.  Current concept on the pathogenesis of inflammatory bowel disease-crosstalk between genetic and microbial factors: pathogenic bacteria and altered bacterial sensing or changes in mucosal integrity take "toll" ?

Authors:  Peter Laszlo Lakatos; Simon Fischer; Laszlo Lakatos; Istvan Gal; Janos Papp
Journal:  World J Gastroenterol       Date:  2006-03-28       Impact factor: 5.742

2.  Failure of epithelial tube maintenance causes hydrocephalus and renal cysts in Dlg5-/- mice.

Authors:  Tamilla Nechiporuk; Tania E Fernandez; Valeri Vasioukhin
Journal:  Dev Cell       Date:  2007-09       Impact factor: 12.270

3.  The Crohn's disease susceptibility gene DLG5 as a member of the CARD interaction network.

Authors:  Frauke Friedrichs; Liesbet Henckaerts; Severine Vermeire; Torsten Kucharzik; Tanja Seehafer; Maren Möller-Krull; Erich Bornberg-Bauer; Monika Stoll; January Weiner
Journal:  J Mol Med (Berl)       Date:  2008-03-12       Impact factor: 4.599

Review 4.  Crohn's disease: an immune deficiency state.

Authors:  Daniel J B Marks; Farooq Z Rahman; Gavin W Sewell; Anthony W Segal
Journal:  Clin Rev Allergy Immunol       Date:  2010-02       Impact factor: 8.667

5.  Role of Dlg5/lp-dlg, a membrane-associated guanylate kinase family protein, in epithelial-mesenchymal transition in LLc-PK1 renal epithelial cells.

Authors:  Takuhito Sezaki; Kohki Inada; Takayuki Sogabe; Kumiyo Kakuda; Lucia Tomiyama; Yohsuke Matsuno; Takafumi Ichikawa; Michinori Matsuo; Kazumitsu Ueda; Noriyuki Kioka
Journal:  PLoS One       Date:  2012-04-23       Impact factor: 3.240

6.  The cloning, genomic organization and tissue expression profile of the human DLG5 gene.

Authors:  Gopi Shah; Ramon Brugada; Oscar Gonzalez; Grazyna Czernuszewicz; Richard A Gibbs; Linda Bachinski; Robert Roberts
Journal:  BMC Genomics       Date:  2002-02-13       Impact factor: 3.969

7.  Expression of polarity genes in human cancer.

Authors:  Wan-Hsin Lin; Yan W Asmann; Panos Z Anastasiadis
Journal:  Cancer Inform       Date:  2015-03-30

8.  Decreased expression of Dlg5 is associated with a poor prognosis and epithelial-mesenchymal transition in squamous cell lung cancer.

Authors:  Juanjuan Che; Jing Wang; Huihui Li; Hongchao Zhen; Kun Shang; Yan Yang; Bangwei Cao
Journal:  J Thorac Dis       Date:  2021-05       Impact factor: 2.895

Review 9.  Central role of the gut epithelial barrier in the pathogenesis of chronic intestinal inflammation: lessons learned from animal models and human genetics.

Authors:  Luca Pastorelli; Carlo De Salvo; Joseph R Mercado; Maurizio Vecchi; Theresa T Pizarro
Journal:  Front Immunol       Date:  2013-09-17       Impact factor: 7.561

Review 10.  DLG5 in cell polarity maintenance and cancer development.

Authors:  Jie Liu; Juan Li; Yu Ren; Peijun Liu
Journal:  Int J Biol Sci       Date:  2014-05-03       Impact factor: 6.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.